High incidence of MYC rearrangement in human immunodeficiency virus‐positive plasmablastic lymphoma

MYC rearrangements are the main cytogenetic alterations in plasmablastic lymphoma (PBL). We aimed to investigate the relationship between MYC rearrangement and the clinicopathological features of PBL.

[1]  Hongzhou Lu,et al.  Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma , 2017, International journal of STD & AIDS.

[2]  Wei Zhang,et al.  Plasmablastic lymphoma , 2017, Medicine.

[3]  G. Elyamany,et al.  Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia , 2015, Diagnostic Pathology.

[4]  L. Medeiros,et al.  Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients , 2015, Journal of Hematology & Oncology.

[5]  Y. Natkunam,et al.  Expression Profiles of MYC Protein and MYC Gene Rearrangement in Lymphomas , 2015, The American journal of surgical pathology.

[6]  Yanping Zhang,et al.  Plasmablastic Lymphoma of the Stomach With C-MYC Rearrangement in an Immunocompetent Young Adult , 2015, Medicine.

[7]  G. Verhoef,et al.  Clinicopathologic Comparison of Plasmablastic Lymphoma in HIV-positive, Immunocompetent, and Posttransplant Patients: Single-center Series of 25 Cases and Meta-analysis of 277 Reported Cases , 2014, The American journal of surgical pathology.

[8]  Y. Cho,et al.  Plasmablastic lymphoma of the oral cavity in a human immunodeficiency virus-negative patient: a case report with literature review. , 2014, Oral surgery, oral medicine, oral pathology and oral radiology.

[9]  A. Rosenwald,et al.  Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. , 2013, Hematology. American Society of Hematology. Education Program.

[10]  M. Taniwaki,et al.  Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age‐related Epstein–Barr virus‐associated B cell lymphoproliferative disorder , 2012, Histopathology.

[11]  K. Rajewsky,et al.  MYC is essential for the formation and maintenance of germinal centers , 2012, Nature Immunology.

[12]  M. Nussenzweig,et al.  The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry , 2012, Nature Immunology.

[13]  A. Bajel,et al.  A case of plasmablastic lymphoma harbouring an IgH/MYC translocation in a HIV negative individual. , 2010, Pathology (Sydney).

[14]  L. Colomo,et al.  IG/MYC Rearrangements are the Main Cytogenetic Alteration in Plasmablastic Lymphomas , 2010, The American journal of surgical pathology.

[15]  E. Jaffe,et al.  Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features , 2010, Modern Pathology.

[16]  N. Karandikar,et al.  Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas , 2010, Modern Pathology.

[17]  Matija Snuderl,et al.  B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma , 2010, The American journal of surgical pathology.

[18]  R. Ashfaq,et al.  Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature. , 2009, American journal of clinical pathology.

[19]  L. Poon,et al.  Plasmablastic Lymphoma Affecting the Lung and Bone Marrow With CD10 Expression and t(8;14)(q24;q32) Translocation , 2009, International journal of surgical pathology.

[20]  S. El-Mofty,et al.  Plasmablastic Lymphoma of Head and Neck: Report of Two New Cases and Correlation with c-myc and IgVH Gene Mutation Status , 2007, Head and neck pathology.

[21]  N. Harris,et al.  Plasmablastic Lymphoma in HIV-Positive Patients: An Aggressive Epstein-Barr Virus-Associated Extramedullary Plasmacytic Neoplasm , 2005, The American journal of surgical pathology.

[22]  A. López-Guillermo,et al.  Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities , 2004, The American journal of surgical pathology.

[23]  B. Barlogie,et al.  Identification of New Nonrandom Translocations in Multiple Myeloma With Multicolor Spectral Karyotyping , 1998 .

[24]  K. Calame,et al.  Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. , 1997, Science.

[25]  D. Huhn,et al.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. , 1997, Blood.

[26]  M. Piris,et al.  Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1 , 2017, Modern Pathology.

[27]  Yi Ding,et al.  Extranodal Natural Killer/T-Cell Lymphoma in Children and Adolescents: A Report of 17 Cases in China. , 2016, American journal of clinical pathology.

[28]  O. Ikpatt,et al.  Extraoral plasmablastic lymphoma with intravascular component and MYC translocation. , 2012, Annals of diagnostic pathology.

[29]  L. Campbell,et al.  AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation--treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A. , 2007, Haematologica.

[30]  G. Gaidano,et al.  Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. , 1993, Blood.